Business Registration Number: 10317663 (Myovant Holdings Limited)
Myovant Sciences Ltd. is a leading biopharmaceutical company dedicated to redefining care for women and for men through purpose-driven science, empowering medicines, and transformative advocacy. Founded in 2016, the company focuses on developing and commercializing innovative therapies for hormone-sensitive conditions, including uterine fibroids, endometriosis, and advanced prostate cancer.
Our value proposition lies in our "patient-first" approach, utilizing advanced clinical research to bring oral alternatives to traditional injectable treatments. By leveraging our deep expertise in GnRH (gonadotropin-releasing hormone) receptor antagonists, we aim to reduce the physical and emotional burden of chronic diseases. Myovant has established significant strategic collaborations with global leaders like Pfizer and Sumitomo Pharma to ensure our life-changing medicines reach patients globally. Following its acquisition by Sumitovant Biopharma in 2023, Myovant continues to operate as a critical pillar of innovation within the Sumitomo Pharma group.
Contact & Location Details
Physical Address: Suite 1, 3rd Floor, 11-12 St. James's Square, London, SW1Y 4LB, United Kingdom
What is Myovant Sciences' primary focus? We specialize in developing therapies for hormone-related conditions, primarily focusing on women's health (endometriosis, uterine fibroids) and oncology (advanced prostate cancer).
Who acquired Myovant Sciences? Myovant was acquired by Sumitovant Biopharma (a subsidiary of Sumitomo Pharma) in March 2023.
What is ORGOVYX®? ORGOVYX® (relugolix) is the first and only oral GnRH receptor antagonist approved by the FDA for the treatment of adult patients with advanced prostate cancer.
Does Myovant offer support for patients who cannot afford medication? Yes, through our Patient Assistance Programs, we aim to provide access to our therapies for eligible patients who face financial barriers.
Where is Myovant's UK office located? Our UK executive office is located at 11-12 St. James's Square, London.
Social Media
Quick Information
Business summaryMyovant Sciences is a biopharma leader specializing in treatments for endometriosis, uterine fibroids, and prostate cancer. Discover our mission and science.
Contact the official Myovant Sciences Ltd. Support Number for fast, reliable assistance in the
Business Services industry. The Myovant Sciences Ltd. customer care team is available
to handle inquiries. You can also access the Myovant Sciences Ltd. official website at
www.myovant.com
for complete service details. For written queries, use the Myovant Sciences Ltd. support email.
Located at Suite 1, 3rd Floor, 11-12 St. James's Square, London, SW1Y 4LB, United Kingdom, London,
Greater London United Kingdom.
Reach the Myovant Sciences Ltd. contact number to connect with verified experts in the
Business Services sector. The Myovant Sciences Ltd. helpline offers quick resolutions
and trusted guidance. You can also contact the Myovant Sciences Ltd. support team through official
Myovant Sciences Ltd. email for professional assistance.